Brigite said: "We are leading an international multi-centre study to further investigate the impact of this heart disorder on the quality of life and life expectancy of affected dogs.
"This is an extremely important research project, so we need the co-operation of referring vets in the area to send cases to us to be included in the study. Clearly, the more cases we can assess then the more we can learn and the more we can help.
"The hope is this study will revolutionise the way in which this condition is treated in dogs around the world, both improving their day-to-day lives as well as giving them longer at home with their families."
For more information, visit: www.willows.uk.net
The awards celebrate the achievements of remarkable people who dedicate their lives to improving animal health and welfare both in the UK and abroad. They are open to vets, vet nurses, farmers, animal welfare professionals and animal welfare teams who can be nominated to receive an award by fellow peers, friends and family or the general public.
There are nine nomination categories including a new one this year to recognise an international individual or team that stands out from the crowd by influencing and significantly contributing to making a visible difference in the world of animal welfare.
The categories are:
Chris Laurence Vet of the Year supported by Vet Record.
Vet Nurse of the Year supported by Agria Pet Insurance
Charity Team of the Year supported by PDSA
Charitable Contribution of the Year supported by Blue Cross
International Cat Care Welfare of the Year supported by International Cat Care
Farmer of the Year supported by R.A.B.I. and Farmers Guardian
Farm Educator of the Year supported by NADIS and Farmers Guardian
Outstanding Contribution to Animal Welfare supported by Your Dog and Your Cat magazines
Outstanding International Contribution to Animal Welfare supported by Ceva International
Nominations can be made at https://www.cevawelfare.com/click-here-to-nominate with nominations closing on Tuesday 31 December 2019.
Finalists will be announced at the beginning of February and winners will be revealed at an awards ceremony in Birmingham in April on the eve of BSAVA Congress.
Cuneyt Seckin, Managing Director of Ceva Animal Health UK and Ireland, said: "As an animal health company, animal welfare is a huge focus for us. The Ceva Animal Welfare Awards are an opportunity to formally recognise and congratulate outstanding animal welfare teams and individuals who contribute to the protection and welfare of animals in their daily lives."
For more information, visit www.cevawelfare.com.
The company says the series will help practices set-up, post content and measure the effectiveness of their social media channels.
There are three introductory videos titled: ‘What are the benefits and why is social media key to my practice?’, ‘Measurement, maintenance and management’ and ‘Planning’.
The first video covers a back-to-basics introduction to social media channels, including Facebook and Instagram. The second video explains how to measure the success of social channels and how to manage posts and content. The final video covers the importance of planning and the use of content calendars to highlight events and awareness days, as well as helpful tools and features such as Facebook Live.
The four how-to guides explain:
The social media videos and how-to guides are part of PetNatter, Boehringer Ingelheim’s free veterinary resource, designed to help veterinary practices stay in touch with owners and help them care for their pets. Originally launched in mid-July, PetNatter provides veterinary practices with professionally crafted social media, newsletter and website content.
Grace Tonner, territory manager at Boehringer Ingelheim said: “Social media plays a big part in our social lives and it is an increasingly important channel in business communities too, which has the potential to help practices maintain and develop vital relationships with pet owners.
"While most vet practices recognise that social media should play an important role in starting and maintaining communications with clients and potential clients, particularly during challenging times such as the COVID-19 pandemic, finding the time, resource and skills to be effective with social media can be challenging.
"Our brilliant series of short, easy-to-understand social media videos and how-to guides provides veterinary professionals with the essential knowledge, tools and confidence to make vet practice social media a hit. Using the videos and guides will enable vet practices to get their social media up and running in just 15 minutes.”
For further information on the social media videos and how-to guides contact your local Boehringer Ingelheim territory manager or visit petnatter.co.uk/how-to.
Zesti comprises three ranges:
The Spirit range is a more standard looking scrub, manufactured from Alsi-Flex. The ‘Mode’ range looks a little more figure hugging, with an exclusive colour palette, and the Power range has a more sporting look.
Greg Houlston, General Manager, said: “Our healthcare workers need clothing that is practical and comfortable above anything else, yet our market research showed us that when it comes to scrubs with stretch, choice is limited in the UK compared with other markets such as the US.
“Veterinarians in particular need workwear that is especially hard wearing as the nature of their work means their clothing can be especially susceptible to rips, tears and soiling.
“We set out to create a brand that answered the need for more flexibility while challenging the perception that workwear should be dull and boring, and Zesti was born – a vibrant and contemporary range of garments, sustainably designed, to inspire confidence and positivity.”
Sara Catanzaro, Design Manager, added: “Our tailored garments offer exceptional attention to detail while being strong, hard wearing and resilient.
"They can be laundered domestically or industrially up to 60 degrees which is ideal for infection control.
"We’re already witnessing considerable demand as we believe we’ve hit the perfect balance between function and fashion.”
For more information, visit www.zesti.co.uk
Virbac Animal Health has launched CaniLeish, the first vaccine for canine leishmaniosis in the European Union.
Leishmaniosis is a vector-borne parasitic disease caused by infection with protozoa of the genus Leishmania (L infantum in Europe). Leishmaniosis is transmitted by the bite of infected sandflies. In south-western Europe 2.5 million dogs are believed to be infected1,2 with the parasite and the disease is spreading northwards,3 as more people travel with their dogs or import infected animals from endemic areas.4 So far preventative methods have been limited to reducing the habitat of sandflies, minimising the physical contact of dogs with sandflies and using insecticides on dogs (sprays, spot-ons, repellent-collars, etc).
According to Virbac, CaniLeish's ability to protect dogs was demonstrated in an experimental challenge study, where the benefit of vaccination was still evident after one year.5 In an extreme condition natural challenge trial lasting two years under environmental conditions rarely encountered in reality, 93% of dogs vaccinated with CaniLeish did not develop symptomatic leishmaniosis. CaniLeish provides a fourfold reduction in the risk of developing this fatal disease. 6 Its safety profile has been shown in laboratory testing and field trials.7 In addition, Virbac says it contains no whole parasites that could be virulent in any host.
David McGahie BVMS Bsc (VetSci) MRCVS, Medical Department Manager at Virbac SA, said: "The development of this vaccine is a key milestone in the battle against this challenging disease which is a major problem in many regions of the world. Although in the past it was considered a rather exotic disease here in the UK, the advent of the Pet Travel Scheme means it has become increasingly important as a problem for dogs which regularly travel abroad to endemic regions."
CaniLeish can be given to dogs as young as six months of age: the primary course consists of three injections given over six weeks. Dogs should be re-vaccinated annually, with a single dose administered one year after the third injection and annually thereafter.
References:
Petplan has announced the results of a survey which shows that with less than a week to go before microchipping becomes compulsory in England, Scotland and Wales, there is still confusion about the law amongst pet owners.
In the survey of 2,000 British dog owners, 25% had not heard of the new law and 40% didn't know that it also requires owners to keep their microchip details up to date.
40% of respondents said they'd be happy to pay over £500 as a reward if their dog went missing. Despite this, 40% of those who were aware of the new law but had yet to chip their dogs admitted they had not done so because of reservations about the cost of the procedure.
The survey also highlighted the fact that even the most careful of owners lose their dogs. Nearly 40% of losses reported in the survey happened when the owner was taking their pet on a daily walk and 47.1% of respondents reported having a dog escape from an apparently secure garden.
The survey also found that a third of lost dogs came to harm while missing, most of which (84.8%) needed veterinary care.
According to Petplan, despite more than half of dog owners citing expensive veterinary bills as one of their biggest concerns around dog ownership, over 45% of respondents reported not having their dogs insured.
Petplan has published information for pet owners about the new microchip law here: petplan.co.uk/microchip-dog-law-info.
The survey, which takes about 5 minutes (I timed it), is designed to canvas opinion about the priorities for learning and development.
Rich Casey, Junior Vice President of the VMG (pictured right), said: "From marketing to HR to financial planning and all points in between, today’s veterinary leaders require expertise in every aspect of running a successful business.
"We want to create a truly valuable, constructive and evidence-based CPD calendar for next year. Views from those working in the profession will help us to fully understand what good leadership and management look like in the veterinary world and we will then make sure that the programme promotes best practice in these important areas. We thank everyone who takes the time to complete the survey."
The survey can be accessed here: https://www.surveymonkey.co.uk/r/VETCPDPR
Fourteen veterinary surgeons stood for election this year and 8,542 voted, a turnout of 24.5% of eligible voters. That compares with a turnout of 26.2% in 2020, 25.5% in 2019 and 22.7% in 2018.
Danny scored a total of 4,759 votes, leaving the other successful candidates Tshidi Gardiner, Colin Whiting and Louise Allum nevertheless trailing in his wake, with 3,228 votes, 2,957 votes and 2,368 votes respectively.
The VN Council election also had fourteen candidates standing for one elected place, the other having been taken by Susan Howarth RVN who was automatically re-elected as the only candidate standing at the time of the original deadline in January.
Donna Lewis was elected with 404 votes from those cast by 2,341 veterinary nurses, which amounted to a turnout of 12.4% of eligible voters. That compares with a turnout of 17.1% in 2020, 14.5% in 2017 and 10.9% in 2016.
All of those elected to either RCVS or VN Councils will formally take up their seats at the RCVS Annual General Meeting on Friday 9 July 2021.
Eleanor Ferguson, RCVS Registrar and Returning Officer for both elections, said: “Thank you to all those who stood as candidates and all those who voted in this year’s elections, especially in view of all the extra demands on everyone’s time at the moment. Many congratulations to our five successful candidates with whom we look forward to working over the coming months and years.
“Even though the elections were held during the ongoing pandemic, the RCVS Council election still produced the third highest turnout on record, and turnout in both elections was above the average for those held over the last ten years.
“As always, we made concerted efforts to let people know about this year’s election, which included additional reminder emails sent on behalf of the RCVS by our election provider Civica Election Services, as well as regular email reminders and social media posts from the RCVS. We do, of course, always endeavour to improve turnout, and will continue to review this going forward.”
Photo: Left to right, Danny Chambers, Tshidi Gardiner, Colin Whiting and Louise Allum.
Running in July, the campaign aims to raise awareness of hyperthyroidism in cats and hypothyroidism in dogs, educate pet owners to spot the symptoms and thereby encourage early diagnosis.
MSD Animal Health says it hopes the campaign will increase the number of pets being taken to their veterinary practice for diagnosis, and increase both return visits and treatment compliance.
Practices supporting Pet Thyroid Month will be supplied with resources to help them educate pet owners about the two conditions.
Caroline Darouj, product manager at MSD Animal Health, said: "Although hyperthyroidism in cats and hypothyroidism in dogs are well known conditions and diagnosis is generally straightforward, a large number of vets in Europe state that both disorders are under-diagnosed, due to the fact that pet owners don’t recognise the signs.
"We wanted to launch our Thyroid Month campaign to encourage pet owners to spot the early symptoms of thyroid issues in their pets and seek advice from their veterinary practices.
"Our aim is also to benefit and educate vets and vet nurses with regard to the use of Leventa and Vidalta in treating these manageable conditions in both dogs and cats."
To find out more about Pet Thyroid Month, visit www.vidalta.co.uk
Squamous cell carcinoma affects horses’ genitalia, eyes, or skin around the eyes. The tumours typically have a guarded to poor prognosis, and the therapeutic approaches available have variable success rates. Euthanasia on welfare grounds is necessary in a significant number of cases.
Before this new research was published, pathologists and researchers Dr Alejandro Suárez-Bonnet and Professor Simon Priestnall, both from the RVC, had already undertaken research which showed that equine squamous cell carcinoma affecting the penis frequently acquires the ability to degrade the extracellular matrix and become much more biologically aggressive2. This is known as ‘epithelial to mesenchymal transition’.
This new study, recently published in Scientific Reports, is the product of a multi-institutional effort, which used both “classical” anatomic histopathology assessment and artificial intelligence to demonstrate a correlation between chronic inflammation, equine papillomavirus infection and progression of equine penile squamous cell carcinoma.
Several additional cancer-related signalling molecules, which are important in researchers’ understanding of human penile cancer, were also studied and the results obtained will lead to a much better understanding and treatment of the cancer.
Simon Priestnall, Professor of Veterinary Anatomic Pathology at the Royal Veterinary College, said: “Equine squamous cell carcinoma is the second most common type of cancer in horses, with a variable prognosis, so we are delighted to have made this breakthrough that provides a greater understanding and can lead to more effective treatments for horses and their owners.
"The RVC has always recognised the value of collaboration, and Alejandro and I enjoyed working alongside the teams at KCL, the University of Edinburgh and UCL. This project shows what can be achieved when different organisations work together with a common aim and we hope the similarities between the tumour in horses and people can offer a true One Health benefit."
Dr Alejandro Suárez-Bonnet, Lecturer in Comparative Pathology at the Royal Veterinary College, said: "I am so pleased with the results of this study, which will hopefully pave the way for improved prognosis of horses diagnosed with equine squamous cell carcinoma.
"Our work is not over, however. Thanks to the help of a grant from the Horse Race Betting Levy, Simon and I are leading a Master’s degree project investigating equine penile, ocular and vulvar squamous cell carcinomas from a broader perspective.
"Our hope is to identify if variability exists between equine papillomavirus infectious status, morphological and microscopic difference, and cancer progression, with the aim of identifying potential therapeutic targets as well as diagnostic markers with prognostic implications for maximum benefit to the British equine population.”
References
Zoetis has launched a 4ml vial of the antibiotic, Convenia.
Zoetis says Convenia gives veterinary surgeons control by providing an assured injectable treatment course, relieving clients of the burden of daily dosing. This avoids missed or mistimed doses, lost tablets, or courses stopped too soon, thereby eliminating a major reason for treatment failure, non-compliance. Poor compliance is also a significant factor in the development of antimicrobial resistance.
Convenia is licensed for skin, soft tissue and urinary tract infections in dogs and cats, as well as severe gingivitis/periodontitis in dogs (as an adjunct to mechanical or surgical periodontal therapy). A 4ml vial can treat up to 40kg of bodyweight, making it appropriate for treating cats and smaller dogs.
Zoetis says that the launch of the new vial demonstrates its commitment to the 'Respect Antibiotics' campaign launched last year. The Respect Antibiotics campaign encourages careful and informed selection of appropriate antibiotic therapies for the treatment of dogs and cats.
Product Manager, Andrew Page, said; "We are committed to encouraging responsible antibiotic usage, and reducing the incidence of antibiotic resistance. Non-compliance plays a key role in the development of antibiotic resistance and we hope that by making Convenia more accessible through the introduction of a 4ml vial we can help alleviate compliance issues."
For further details about Convenia please contact your Zoetis Account Manager.
The programme, which will look at the achievements and contributions of people of African and Afro-Caribbean descent, will see Dr Greene being interviewed by presenter Alex Beresford alongside a number of other prominent black Britons including athlete and broadcaster Colin Jackson, publisher and author Margaret Busby, Mayor of Bristol Marvin Rees, and nurse and academic Dame Elizabeth Anionwu.
Mandisa said: “I am immensely honoured to be the first Black President of the RCVS and to use this opportunity to speak to the black community, and indeed all communities, about my love of veterinary science and the importance of the work we do in safeguarding animal health and welfare and wider public health.
"I am a great believer in the phrase ‘if you see it, you can be it’ and I hope that my various talks this month and, particularly the upcoming ITV documentary, will help people recognise that veterinary professionals can come from a diverse range of backgrounds and that, provided they have the drive and the ambition, there should be no barriers to them meeting their dreams."
The study analysed information from a random sample of 29,865 dogs that died over a one-year period, taken from a study population of 905,544 dogs from 626 clinics in the VetCompass database.
From the sample, 26,676 (91.5%) of deaths recorded in practice involved euthanasia and 2,487 (8.5%) of deaths were unassisted. However, it is unknown how many dogs die unassisted and unreported to a practice.
Perhaps unsurprisingly, the findings indicated that certain types of diseases and conditions were more likely to lead to death by euthanasia than unassisted death.
by contrast,
Larger bodyweights, increasing age and certain breeds of dog were also additional risk factors for euthanasia. Rottweilers were more likely to die by euthanasia compared to Labrador Retrievers as the standard baseline breed. In contrast, breeds such as Bulldogs, Pugs and West Highland White Terriers were more likely to have unassisted deaths, and these deaths were more likely caused by traumatic injury, foreign body and heart disease.
Additional findings from the study included:
Camilla Pegram, VetCompass Epidemiologist at the RVC, and author of the paper, said: “End-of-life discussions between veterinarians and owners can be particularly difficult for both parties. This study provides benchmark data for the relative proportion of deaths that involve euthanasia and for the relative impact from demographics and disorders on euthanasia decision-making. Owners and veterinary professionals may find it easier to discuss end-of-life options, to reach a final decision and be comfortable with these decisions based on a feeling of broader support from the reported actions of others in similar situations.”
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and co-author of the paper, said: "The decision for many animal owners to put a beloved dog to sleep is often the hardest decision of their life. The moment of euthanasia often lives with owners forever. Hopefully, the information from this study can at least help some owners come to terms with the responsibility of helping their dog go with dignity. Understanding that over 90% of other owners also opted for euthanasia may help anyone struggling to make this final and hardest decision.”
Dr Carol Gray, Research Associate at the University of Liverpool and co-author of the paper, said: "Decision-making around euthanasia is shared between veterinarian and owner, although it is the owner who must give consent for euthanasia. Providing this final authorisation is potentially a burden for owners. This paper will help to ease that burden by allowing veterinarians to provide reassurance that they are not the only dog owners to make a decision for euthanasia in similar circumstances.”
Reference
Pegram, C., Gray, C., Packer, R.M.A. et al. Proportion and risk factors for death by euthanasia in dogs in the UK. Sci Rep 11, 9145 (2021). https://doi.org/10.1038/s41598-021-88342-0
Ceva Animal Health is launching Fiprospot, a new spot-on for dogs and cats.
Fiprospot contains fipronil, with its proven efficacy against fleas in dogs and cats and against ticks in dogs. The product is packaged in a novel dosing pipette which can be placed on its stand before gathering the dog or cat for their treatment. There are five pack sizes available for Fiprospot: one for cats and four for dogs, with either three or six pipettes per pack.
To find out more about Fiprospot and other products in Ceva's antiparasite range, telephone the customer support team on (01494) 781510 or contact your local Ceva territory manager.
The most recent case of rabies in a bat in Great Britain was in July 2020 in Wimbourne, Dorset and there were four cases in 2019.
Like many wild animals, bats can carry a number of different pathogens, including European Bat Lyssaviruses (EBLVs) 1 and 2 – also referred to as bat rabies. The rabies virus is present in the saliva of infected bats and is usually spread to humans or other mammals by the bite of an infected bat. The virus may also enter the body via open wounds or mucous membranes.
The BSAVA says that whilst the risk of transmission to humans is considered low, those handling bats may be at an increased risk of contracting the disease and those who regularly handle bats should be vaccinated against rabies.
Those who are not vaccinated against the disease should assume that all bats are possible carriers of rabies. Individuals handling bats should wear gloves of a suitable thickness for the species of bat they are handling to avoid being bitten or scratched. Further information on how to safely contain and handle a bat can be found on the Bat Conservation Trust website.
In the event that an individual is bitten or scratched by a bat or exposed to bat saliva or nervous tissue in any other way, they should seek immediate medical advice. The contact area should be washed with soap and water, and any wounds must be disinfected. Further information can be found on the APHA, PHE and NHS websites.
In 2008, a case involving an injured bat carrying EBLV type 2 was treated by a vet and her staff, who were unaware of the potential of rabies risk from bats. The bat handlers had previously been vaccinated as recommended by the Department of Health but despite sustaining a needlestick injury during surgery, the vet and her staff had neither sought nor received post-exposure prophylaxis.1
Professor Ian Ramsey, president of the BSAVA, said: “Although this case was 12 years ago it is a pertinent reminder of why we need to be well-prepared when handling bats. Whilst the risk of human rabies infection from bats is low, the publication of the new statistics show that EBLVs are circulating in a small number of wild bats. Injured bats are often presented to small animal vets, so we have taken this opportunity to remind our members and others of the potential risks of rabies transmission, and how to mitigate against these.
"For more advice on the handling and treatment of wildlife casualties including bats, we advise vets to consult a reference book such as the BSAVA Manual of Wildlife Casualties."
Redonyl Ultra contains essential fatty acids, Palmitoylethanolamide (PEA) and Biotin.
PEA is a naturally-occurring bio modulator which Dechra says has scientifically proven activity against the mechanisms that contribute to inflammation and pain, while Biotin is important for synthesis of fatty acids and support of optimal skin condition.
Dechra Brand Manager Claire Morgan said: "Redonyl Ultra is a great addition to Dechra’s extensive Dermatology range that allows an holistic approach to treatment, control and maintenance of dermatological conditions.
"Allergic skin conditions are among the most common causes of skin and ear disease in cats and dogs, and it is estimated that up to 15 per cent of dogs are affected by atopy. In situations where an allergen cannot be avoided, multi-modal therapy is useful to control the clinical signs."
Redonyl Ultra comes in a convenient bottle size of 60 skittle capsules, in two strengths for different sized animals. The capsules can be opened and given with food or ingested directly, or swallowed whole for flexible administration.
For more information, visit http://bit.ly/2iNa2Ik
FirstVet says the funding will enable it to expand its service globally, including the United States, Germany, and France. It will also allow it to continue developing its product and introduce new features to improve the experience for pet owners and vets, such as new automation tools and integration with clinics' existing systems.
The latest round of financing takes FirstVet’s total funding to-date to €24.5M.
Founded in 2016 in Sweden, FirstVet currently has a presence in five markets: the United Kingdom, Norway, Denmark, Finland, and its native Sweden. The company says it has over 200,000 registered users and has provided consultations for over 150,000 pets since launch.
Currently, FirstVet consultations are offered free to millions of owners through partnerships with 20 insurance companies across all markets, including Bought By Many in the UK.
Co-founder David Prien said: "FirstVet is the first truly neutral stakeholder in the world to coordinate pet care. In what is a highly privatised industry, our reliable service provides value to the entire sector, and we are growing at an incredible rate."
Virbac points to how the pandemic has caused a fundamental shift in consumer shopping habits, with e-commerce accounting for more than 30% of retail sales in the UK in 2020 for the first time1.
Alongside the increase in online sales has come an expectation by consumers that all companies should provide a reliable digital service, with 70% saying that they will continue to buy essential goods online post-pandemic2.
At the same time, sales of pet food in the majority of veterinary practices have been hit by the need for social distancing.
Through the new model, when pet owners buy Virbac's low-carb, high protein Veterinary HPM dog and cat food from the company's new web store for home delivery, a commission is paid to the practice.
Remi Mandray, Product Manager at Virbac said: "It’s a win-win for our practices and their clients, who can take advantage of this convenient option to have their pet food delivered to their home, whilst providing the practice with a protected and rewarding business model".
For more information, contact your Virbac Territory Manager.
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Lecture topics will include interesting cases, the importance of systematic abdominal technique, the challenge of becoming ultrasound competent within a primary referral setting, basic anaesthetic nerve blocks, using ultrasound for appropriate medical management, how CASE can support competency based veterinary ultrasound training and more.
The session will end with a debate on whether it is time for a formal / stand alone Veterinary Ultrasound training programme and who should accredit such courses.
Speakers include Natasha Dickinson from Cave Veterinary Specialists, Niamh Casey from Village Vets, Miguel Martinez from Northwest Veterinary Specialists, Will Humphreys from the University of Liverpool and Nuala Summerfield from Virtual Veterinary Specialists.
The day costs £75 (sounds like a steal, if you ask me), and you can register here: https://www.bmus.org/meeting-booking/ultrasound-2019/
The app, which works on tablets and smartphones, allows vets to e-mail audit results directly to clients following an interactive calf health assessment at the farm.
MSD Animal Health’s youngstock marketing manager Robert Simpson said: “Our new app allows both parties to explore, record and score calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
“Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention.
"What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets”.
For more information about the app, contact your MSD account manager.
Bayer Animal Health has taken over the marketing and sales of the antibiotic Nisamox (tablets containing Amoxicillin and Clavulanic Acid), from Fort Dodge Animal Health.
Under the new arrangement, the design of Nisamox tablet packaging will change to reflect the change of ownership, however, Bayer says the quality of the tablets and the competitive pricing remain unchanged.
Nisamox tablets are licensed for use in cats and dogs to treat infections of the skin, urinary tract, and respiratory tract caused by susceptible Staphylococci, and also to treat enteritis and urinary tract infections caused by susceptible E.coli.
Nisamox tablets will continue to be available in three strengths: 50mg, 250mg, and 500mg. For information on Nisamox tablets, contact your Bayer territory manager.
Dr Pete Down, Associate Dean for Undergraduate Education in UCLan’s School of Veterinary Medicine, said: “We recognise the multifaceted challenges the profession is facing at the moment, but many of us have spent significant time out in practice and recognise that it can be a fantastic career.
“Additionally, first-opinion vets provide essential services to the pet-owning public, equine, and farming industries.
"Our curriculum focusses on the provision of contextual-care and encourages vet students to see general practice as a fantastic career in and of itself.
"Also, whilst diversity in the profession has traditionally been a challenge, our student recruitment practices support an inclusive approach, recruiting students from a wide variety of backgrounds.”
The practically focused curriculum is ‘hands-on’ from year one and the university says it uses innovative digital technologies from the outset: its students will be among the first in the country to use specialist Anatomage vet tables.
Dr Heather Bacon OBE, Dean of UCLan’s School of Veterinary Medicine, said: “It’s a landmark day for the University as we’ve welcomed our first cohort of veterinary medicine students through the door.
"The demand for places on the first year of our BVMS course was huge and I’m thrilled we’ve been able to enrol so many enthusiastic student vets on to our programme.”
https://www.uclan.ac.uk/undergraduate/courses/veterinary-medicine-surgery-bvms
Abbott Animal Health is launching GLUture Topical Tissue Adhesive this month.
Abbott says GLUture is an Octyl/Butyl cyanoacrylate blend that creates a strong and flexible bond that contours to the wound site. GLUture applies purple for visibility and dries clear for a neat cosmetic appearance. Offered in an economical multi-use package with 10 applicators, GLUture's viscosity and applicator design enable flow-controlled application. GLUture topical tissue adhesive offers a flexible seal, quick application and a strong bond.
For more information, ring Abbott on 01628 644354, or visit: www.abbottanimalhealth.com
The new tool uses aggregated data from Banfield Pet Hospital medical records to identify whether a dog has a high, medium, or low risk of having PD based on the breed size1,2,3,4,5, age, and body condition the owner has stated3,4.
It also makes oral care recommendations based on the dog's history (e.g., diet, previous extractions, halitosis), clinical signs (e.g., bleeding gums) and current dental routine (e.g., tooth brushing).
Global Petcare R&D VP at Mars Pet Nutrition, Dr. Elise Malandain said: “This new risk assessment tool will help indicate to pet owners what level of risk their pet is at for developing this disease to help inform conversations with veterinary professionals about prevention or treatment.”
https://www.uk.pedigree.com/gum-disease-risk-checker